Alpine Associates Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,163,900
| Closed | -$3.56M | – | 69 |
|
|
2020
Q4 | $3.56M | Sell |
5,163,900
-675,100
| -12% | -$466K | 0.15% | 40 |
|
|
2020
Q3 | $13.1M | Buy |
5,839,000
+1,218,700
| +26% | +$2.74M | 0.69% | 24 |
|
|
2020
Q2 | $16.5M | Sell |
4,620,300
-947,030
| -17% | -$3.39M | 0.95% | 20 |
|
|
2020
Q1 | $21.2M | Sell |
5,567,330
-3,604,886
| -39% | -$13.7M | 0.84% | 27 |
|
|
2019
Q4 | $27.6M | Buy |
+9,172,216
| New | +$27.6M | 0.88% | 29 |
|